Quick Answer: Hydroquinone is the strongest and fastest-acting prescription pigmentation treatment, best for significant sun spots and melasma. Kojic acid is a gentler, prescription-free alternative suited to mild pigmentation and sensitive skin. Azelaic acid treats both pigmentation and acne, and is safe during pregnancy. The right choice depends on your pigmentation type, skin sensitivity, and whether you can obtain a prescription.
If you have been researching treatments for sun spots, melasma, or uneven skin tone, you have almost certainly encountered all three: hydroquinone, kojic acid, and azelaic acid. They are among the most commonly prescribed and recommended depigmenting ingredients in Australian dermatology. However, they work differently and suit different skin types, and as such, are not equally effective for all types of pigmentation.
This guide compares all three directly, their mechanisms, effectiveness, availability in Australia, and who each one is best suited for so you can have an informed conversation with your GP or dermatologist about which approach fits your situation.
| Hydroquinone | Kojic Acid | Azelaic Acid | |
|---|---|---|---|
| How it works | Inhibits tyrosinase enzyme to block melanin production | Inhibits tyrosinase; chelates copper ions needed for melanin synthesis | Inhibits tyrosinase + anti-inflammatory + mild exfoliant |
| Strength | Strongest, fastest results | Moderate | Moderate |
| Prescription needed? | Yes, above 2% in Australia | No (but Rx concentrations available) | Yes (Rx concentrations); low % OTC |
| Best for | Moderate severe sun spots, melasma, PIH | Mild sun spots, maintenance, sensitive skin | Mild-moderate pigmentation + acne/rosacea skin; safe in pregnancy |
| Safe in pregnancy? | No | Limited data | Yes (one of very few safe options) |
| Typical timeline | 4–8 weeks visible results | 8–16 weeks | 8–12 weeks |
| Compoundable? | Yes, 4–10% with other actives | Yes, with other actives | Yes, 10–20% in various bases |
Hydroquinone remains the most clinically studied and most effective single-ingredient depigmenting agent available. Decades of dermatology research support its use as a first-line treatment for moderate-to-significant hyperpigmentation, and it consistently outperforms alternatives in head-to-head studies for conditions like melasma and solar lentigines (sun spots).
In Australia, hydroquinone above 2% is a prescription-only medicine. The standard treatment concentration is 4%, though compounding pharmacies can prepare higher concentrations (5–10%) under dermatologist supervision for resistant pigmentation. The most well-studied combination is Kligman’s formula, hydroquinone with tretinoin and a mild corticosteroid, which produces faster and more complete results than hydroquinone alone.
Best for: Moderate to significant sun spots, melasma, post-inflammatory hyperpigmentation, patients who have not responded adequately to gentler options, and any patient whose prescriber recommends it as first-line treatment.
Not ideal for: Patients who cannot obtain a prescription, those with very sensitive skin at risk of irritation, or patients who are pregnant or breastfeeding.
Kojic acid is derived from fungi and works by chelating copper ions that are essential to the tyrosinase enzyme, thereby reducing melanin synthesis. It is gentler than hydroquinone and does not require a prescription in Australia at commonly available concentrations, making it accessible in cosmeceutical skincare products.
The trade-off is effectiveness. Kojic acid works more slowly and produces more modest results than hydroquinone for significant pigmentation. For mild sun spots, freckles, or as a maintenance treatment after completing a hydroquinone course, it is a practical and well-tolerated option.
A common compounded combination is kojic acid with vitamin C or azelaic acid, which amplifies the effect while staying within a tolerable range for sensitive skin types. Some patients who cannot tolerate hydroquinone at 4% find a kojic acid combination an effective alternative.
Best for: Mild pigmentation, maintenance after hydroquinone treatment, sensitive skin types who experience irritation with hydroquinone, patients who prefer to avoid prescription products for minor pigmentation concerns.
Not ideal for: Significant or stubborn melasma, deep post-inflammatory pigmentation, or patients looking for the fastest possible results.
Azelaic acid is a dicarboxylic acid that targets tyrosinase, the same enzyme as hydroquinone and kojic acid, but also has anti-inflammatory and mild antimicrobial properties. This makes it uniquely suited to patients whose pigmentation coexists with active acne, rosacea, or sensitive, reactive skin.
Its most significant clinical advantage is safety in pregnancy. Melasma is extremely common during pregnancy due to hormonal changes, but most pigmentation treatments, including hydroquinone and tretinoin, are contraindicated during pregnancy and breastfeeding. Azelaic acid at 15–20% is one of the very few prescription treatments considered safe for use during pregnancy under medical supervision.
In Australia, higher-concentration azelaic acid formulations (15–20%) are prescription-only. Compounding allows these concentrations to be prepared in bases suited to your skin type, and can be combined with other pregnancy-safe actives where appropriate.
Best for: Pigmentation occurring alongside acne or rosacea, pregnant or breastfeeding patients with melasma, patients with sensitive or inflammatory skin types who do not tolerate hydroquinone, mild-to-moderate pigmentation requiring a gentler multi-benefit treatment.
Not ideal for: Patients who need the fastest possible results, or significant sun spots where hydroquinone would produce demonstrably better outcomes.
Yes, and combination formulations are often more effective than any single ingredient alone. This is one of the key applications of compounding pharmacy in dermatology: preparing custom formulations that combine ingredients not available as a single commercial product.
Common compounded pigmentation combinations include:
Your dermatologist or GP can prescribe a combination formula tailored to your specific pigmentation type, skin sensitivity, and treatment history, which NCC can compound and deliver to you across Australia.
The right answer depends on your specific situation:
For many patients, the most effective approach is not a single ingredient in isolation, it is a compounded combination prescribed by a dermatologist that uses two or more of these actives together in a base suited to your skin type.
No, for moderate-to-significant sun spots, hydroquinone 4% consistently outperforms kojic acid in clinical studies. Kojic acid is effective for mild pigmentation and as a maintenance ingredient, but patients with significant sun spots or melasma typically see faster and more complete results with prescription-strength hydroquinone.
In theory, yes, they each work through compatible mechanisms. However, combining multiple active ingredients increases the risk of irritation. Rather than layering separate products, discuss with your dermatologist whether a compounded combination formula would be appropriate. A compounding pharmacist can prepare the right actives in the right concentrations in a single formulation suited to your skin.
The most evidence based treatment for melasma in Australia is Kligman’s formula, a compounded combination of hydroquinone, tretinoin, and a low-potency corticosteroid. This combination consistently outperforms single-ingredient treatments in clinical trials. It requires a prescription and is typically prepared by a compounding pharmacy. Daily broad-spectrum SPF 50+ is a non-negotiable part of any melasma treatment protocol.
No, hydroquinone is not banned in Australia. It is regulated as a Schedule 4 Prescription Only Medicine at concentrations above 2%, which means it requires a prescription from a GP or dermatologist. It is available at prescription-strength concentrations from compounding pharmacies like NCC across Australia.
Azelaic acid (15–20%) is considered one of the safest prescription options for pigmentation treatment during pregnancy and is commonly used for pregnancy-related melasma under medical supervision. Hydroquinone, tretinoin, and many other pigmentation treatments are not recommended during pregnancy. Always discuss with your GP or obstetrician before starting any skin treatment while pregnant.
Kojic acid typically takes 8–16 weeks to produce visible results, compared to 4–8 weeks for hydroquinone 4%. The difference is clinically significant if you are hoping to address pigmentation quickly. If timeline is a priority, prescription-strength hydroquinone, possibly in a combination formula, is generally the more appropriate choice.
Yes. NCC can compound custom pigmentation formulations that combine hydroquinone with kojic acid, azelaic acid, or other actives at the concentrations prescribed by your doctor. This is one of the advantages of compounding, commercial products cannot accommodate this level of customisation, but a compounding pharmacist can prepare precisely what your dermatologist prescribes.